AU2021422067A1 - Gene transcription framework, vector system, genome sequence editing method and application - Google Patents

Gene transcription framework, vector system, genome sequence editing method and application Download PDF

Info

Publication number
AU2021422067A1
AU2021422067A1 AU2021422067A AU2021422067A AU2021422067A1 AU 2021422067 A1 AU2021422067 A1 AU 2021422067A1 AU 2021422067 A AU2021422067 A AU 2021422067A AU 2021422067 A AU2021422067 A AU 2021422067A AU 2021422067 A1 AU2021422067 A1 AU 2021422067A1
Authority
AU
Australia
Prior art keywords
sequence
dna
artificial sequence
gene
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021422067A
Other languages
English (en)
Inventor
Shuanghong PENG
Yunpeng SUI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2021422067A1 publication Critical patent/AU2021422067A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/106—Plasmid DNA for vertebrates
    • C12N2800/107—Plasmid DNA for vertebrates for mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/90—Vectors containing a transposable element

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Management Or Editing Of Information On Record Carriers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2021422067A 2021-01-22 2021-12-01 Gene transcription framework, vector system, genome sequence editing method and application Pending AU2021422067A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202110089068.1A CN112708636A (zh) 2021-01-22 2021-01-22 基因转录框架、载体系统、基因组序列编辑方法及应用
CN202110089068.1 2021-01-22
PCT/CN2021/134710 WO2022156378A1 (zh) 2021-01-22 2021-12-01 基因转录框架、载体系统、基因组序列编辑方法及应用

Publications (1)

Publication Number Publication Date
AU2021422067A1 true AU2021422067A1 (en) 2023-09-07

Family

ID=75550451

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021422067A Pending AU2021422067A1 (en) 2021-01-22 2021-12-01 Gene transcription framework, vector system, genome sequence editing method and application

Country Status (11)

Country Link
US (1) US20250263737A1 (https=)
EP (1) EP4282968A4 (https=)
JP (1) JP2024504592A (https=)
KR (1) KR20230135630A (https=)
CN (1) CN112708636A (https=)
AU (1) AU2021422067A1 (https=)
BR (1) BR112023014382A2 (https=)
CA (1) CA3206081A1 (https=)
MX (1) MX2023008635A (https=)
WO (1) WO2022156378A1 (https=)
ZA (1) ZA202308025B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112481259B (zh) * 2020-11-24 2022-09-16 南昌大学 两种甘薯U6基因启动子IbU6的克隆与应用
CN115044583A (zh) * 2022-03-21 2022-09-13 隋云鹏 用于基因编辑的rna框架和基因编辑方法
CN115312121B (zh) * 2022-09-29 2023-03-24 北京齐碳科技有限公司 靶基因位点检测方法、装置、设备及计算机存储介质

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2281050B1 (en) * 2008-04-14 2014-04-02 Sangamo BioSciences, Inc. Linear donor constructs for targeted integration
CN102080101B (zh) * 2010-11-25 2013-01-09 北京济福霖生物技术有限公司 一种定点整合外源基因的方法
WO2016030501A1 (en) * 2014-08-28 2016-03-03 Centre National De La Recherche Scientifique - Cnrs - Synthetic alu-retrotransposon vectors for gene therapy
US11339427B2 (en) * 2016-02-12 2022-05-24 Jumpcode Genomics, Inc. Method for target specific RNA transcription of DNA sequences
CN113286880A (zh) * 2018-08-28 2021-08-20 旗舰先锋创新Vi有限责任公司 调控基因组的方法和组合物
US20210340562A1 (en) * 2018-10-19 2021-11-04 Board Of Regents, The University Of Texas System Engineered long interspersed element (line) transposons and methods of use
JP7831937B2 (ja) * 2019-09-03 2026-03-17 クリエイト・メディシンズ，インコーポレーテッド ゲノム組込みのための方法および組成物
CN112210573B (zh) * 2020-10-14 2024-02-06 浙江大学 一种用基因编辑改造原代细胞的dna模板及定点插入方法

Also Published As

Publication number Publication date
EP4282968A4 (en) 2024-12-04
JP2024504592A (ja) 2024-02-01
BR112023014382A2 (pt) 2023-10-31
CN112708636A (zh) 2021-04-27
US20250263737A1 (en) 2025-08-21
ZA202308025B (en) 2024-03-27
CA3206081A1 (en) 2022-07-28
KR20230135630A (ko) 2023-09-25
MX2023008635A (es) 2023-10-17
EP4282968A1 (en) 2023-11-29
WO2022156378A1 (zh) 2022-07-28

Similar Documents

Publication Publication Date Title
US5814500A (en) Delivery construct for antisense nucleic acids and methods of use
US7294504B1 (en) Methods and compositions for DNA mediated gene silencing
JP5823969B2 (ja) 心臓特異的核酸調節因子ならびにこの方法および使用
CN113939591A (zh) 编辑rna的方法和组合物
AU2021422067A1 (en) Gene transcription framework, vector system, genome sequence editing method and application
DiDonato et al. Regulation of murine survival motor neuron (Smn) protein levels by modifying Smn exon 7 splicing
JPH08510130A (ja) 異常スプライシングを阻害するアンチセンスオリゴヌクレオチドと同物質の利用法
KR20230029891A (ko) 전이유전자 발현 시스템
WO2005014810A1 (ja) ダンベル型ｄｎａの効率的な製造方法
US20050196862A1 (en) DNA cassette for cellular expression of small RNA
Speek et al. Alternate promoters and alternate splicing of human tenascin-X, a gene with 5′ and 3′ ends buried in other genes
US20070054872A1 (en) Regulatable or conditional expression systems
US7741113B2 (en) Cell-specific molecule and method for importing DNA into osteoblast nuclei
WO2024020114A2 (en) Genome insertions in cells
WO2023018938A1 (en) Methods for generation of precise rna transcripts
EP4288548A1 (en) Fusion proteins for crispr-based transcriptional repression
CN112481272A (zh) Nova1促smn2外显子7列入的验证方法及其应用
US20250090690A1 (en) Methods and systems for correcting mutations in prph2
CN119592567B (zh) 基于肿瘤剪接转换治疗的反义寡核苷酸及其应用
JP2025533501A (ja) ポンペ病マウスモデルの生成、特徴決定および使用方法
CN120189530A (zh) 基因编辑系统及其应用
EP4692346A1 (en) Crrna having modified nucleotide
JP2025500685A (ja) ヌクレオチド及びその使用
EP4490291A1 (en) Precise excisions of portions of exons for treatment of duchenne muscular dystrophy
HK40061041A (en) Methods and compositions for editing rnas